Legence Corp. Class A LGN 深 沪
等待开盘 05-14 09:30:00 美东时间
100.00
+2.340
+2.40%
华盛通- 最 高102.505
- 今 开98.21
- 成交量 182.01万股
- 最 低 95.1101
- 昨 收 97.66
- 总市值 108.04亿
- 52周最高 102.635
- 市盈率 静 --
- 换手率 1.68%
- 52周最低 26.96
- 委 比 93.60%
- 总股本 1.08亿
- 历史最高 102.635
- 量 比 0.99
- 振 幅 7.57%
- 历史最低 26.96
- 每 手 1
- 风险率 16.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Shares of companies in the broader industrials sector are trading lower. Hotter-than-expected U.S. inflation data and pressure from elevated energy prices may dampen sentiment regarding capital investments.
Shares of companies in the broader industrials sector are trading lower. Hotter...
05-13 01:47
美股大行评级 | 瑞银：维持Visa"买入"评级！目标价从390美元升至410美元
今日重点评级关注：HC Wainwright & Co.：维持Protara Therapeutics"买入"评级，目标价从23美元升至27美元；BTIG：维持Black Diamond Therapeutic"买入"评级，目标价从10美元升至11美元
04-30 19:24
Loop Capital Initiates Coverage On Legence with Buy Rating, Announces Price Target of $96
Loop Capital analyst Jeffrey Stevenson initiates coverage on Legence (NASDAQ:LGN) with a Buy rating and announces Price Target of $96.
04-29 21:12
美股夜盘 | Intellia Therapeutics, Inc.涨37.20%，Organon & Co.涨14.03%
Intellia Therapeutics, Inc.涨37.20%；Organon & Co.涨14.03%；克里夫天然资源公司涨10.25%
04-27 10:01
美股大行评级 | 瑞银大幅上调西部数据、希捷科技目标价！汇丰银行上调英特尔评级至"买入"，目标价从50美元升至95美元
今日重点评级关注：HC Wainwright & Co.：维持Century Therapeutics"买入"评级，目标价从2美元升至5美元；Oppenheimer：维持Climb Bio"跑赢大市"评级，目标价从10美元升至18美元
04-22 12:41
美股大行评级 | 美国银行、摩根士丹利、JB亨特运输服务、PNC金融服务、Cheniere Energy等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持FibroBiologics"买入"评级，目标价从4美元升至8美元；摩根士丹利：维持Ultragenyx药业"超配"评级，目标价从50美元升至67美元
04-17 11:27
Goldman Sachs Maintains Buy on Legence, Raises Price Target to $72
Goldman Sachs analyst Adam Bubes maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $63 to $72.
04-16 19:44
Legence Says Selling Stockholders Affiliated With Blackstone Intend To Offer And Sell 11M Shares Of Legence's Class A Common Stock In Secondary Underwritten Public Offering
Legence Corp. (NASDAQ:LGN) ("Legence" or the "Company") today announced that selling stockholders affiliated with Blackstone Inc. (the "Selling Stockholders") intend to offer and sell 11,000,000 shares of Legence's Class
04-06 19:26
美股大行评级 | 潜在涨幅172.14%！Alumis获Oppenheimer上调目标价至55美元；摩根大通首予希捷科技"超配"评级，目标价525美元
今日重点评级关注：Oppenheimer：维持Alumis"跑赢大市"评级，目标价从50美元升至55美元；美银证券：维持Rocket Pharmaceuticals"买入"评级，目标价从8美元升至9美元
03-31 16:30
Legence Analysts Boost Their Forecasts After Q4 Results
Legence Corp. reported mixed Q4 results, with earnings missing estimates but sales beating expectations. FY2026 sales guidance also raised.
03-30 23:23
